ACLARION, INC. Financing Cash Flow
ACLARION, INC. (ACON) reported Financing Cash Flow of $9.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- ACLARION, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$19.28K.
- ACLARION, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $9.68M, a 42.67% decline year-over-year.
- ACLARION, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.34M, a 1772.55% increase year-over-year.
- ACLARION, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$283.80K, a 121.85% decline year-over-year.
- ACLARION, INC. net cash provided by (used in) financing activities for fiscal 2025 was $18.95M, a 276.93% increase from fiscal 2024.
- ACLARION, INC. net cash provided by (used in) financing activities for fiscal 2024 was $5.03M, a 51.63% increase from fiscal 2023.
- ACLARION, INC. net cash provided by (used in) financing activities for fiscal 2023 was $3.31M, a 46.43% decline from fiscal 2022.
- ACLARION, INC. net cash provided by (used in) financing activities for fiscal 2022 was $6.19M, a 110.49% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$19.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.66M 10-Q · filed 2026-08-06 | $12.00M derived: sum of 3 quarters · filed 2026-08-06 | $11.72M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $9.68M 10-Q · filed 2026-05-13 | $12.02M derived: sum of 2 quarters · filed 2026-05-13 | $11.74M derived: sum of 3 quarters · filed 2026-05-13 | $11.74M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $2.06M derived: sum of 2 quarters · filed 2026-03-18 | $2.06M derived: sum of 3 quarters · filed 2026-08-06 | $18.95M 10-K · filed 2026-03-18 | |||
| 2025-09-30 | -$283.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$283.80K derived: sum of 2 quarters · filed 2026-08-06 | $16.60M 10-Q · filed 2025-11-12 | $16.73M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.89M 10-Q · filed 2026-08-06 | $17.01M derived: sum of 3 quarters · filed 2026-08-06 | $18.31M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $16.89M 10-Q · filed 2026-05-13 | $17.01M derived: sum of 2 quarters · filed 2026-05-13 | $18.31M derived: sum of 3 quarters · filed 2026-05-13 | $18.50M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $125.14K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.42M derived: sum of 2 quarters · filed 2026-03-18 | $1.61M derived: sum of 3 quarters · filed 2026-03-18 | $5.03M 10-K · filed 2026-03-18 | |||
| 2024-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.49M derived: sum of 2 quarters · filed 2025-11-12 | $4.90M 10-Q · filed 2025-11-12 | $6.53M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $188.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.60M 10-Q · filed 2025-08-14 | $5.23M derived: sum of 3 quarters · filed 2025-08-14 | $5.75M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $3.41M 10-Q · filed 2025-05-15 | $5.04M derived: sum of 2 quarters · filed 2025-05-15 | $5.56M derived: sum of 3 quarters · filed 2025-05-15 | $6.73M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $2.15M derived: sum of 2 quarters · filed 2025-04-09 | $3.31M derived: sum of 3 quarters · filed 2025-04-09 | $3.31M 10-K · filed 2025-04-09 | |||
| 2023-09-30 | $522.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.69M derived: sum of 2 quarters · filed 2024-11-14 | $1.69M 10-Q · filed 2024-11-14 | $1.69M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.17M 10-Q · filed 2024-08-14 | $1.17M derived: sum of 3 quarters · filed 2024-08-14 | $1.17M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | $6.19M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $6.19M derived: sum of 3 quarters · filed 2024-03-28 | $6.19M 10-K · filed 2024-03-28 | $6.55M 10-K · filed 2023-02-27 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.19M derived: sum of 2 quarters · filed 2023-11-14 | $6.19M 10-Q · filed 2023-11-14 | $6.55M 10-Q · filed 2022-11-14 | $6.19M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $6.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-25 | $6.19M 10-Q · filed 2023-08-25 | $6.55M 10-Q · filed 2022-08-15 | $6.19M derived: sum of 3 quarters · filed 2023-08-25 | $6.24M derived: sum of 4 quarters · filed 2023-08-25 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-07-03 | $0.00 derived: sum of 2 quarters · filed 2023-07-03 | $50.00K derived: sum of 3 quarters · filed 2023-07-03 | $2.62M derived: sum of 4 quarters · filed 2023-07-03 | |||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $50.00K derived: sum of 2 quarters · filed 2023-06-12 | $2.62M derived: sum of 3 quarters · filed 2023-06-12 | $2.94M 10-K/A · filed 2023-06-12 | |||
| 2021-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.62M derived: sum of 2 quarters · filed 2022-11-14 | $2.94M 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.89M 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | $319.00K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |